US 2020/0399392 A1Published application

Inhibitors of pla2-g1b cofactors for treating cancer

AssigneeDiaccurate

InventorsJULIEN POTHLICHET, PHILIPPE POULETTY, JACQUES THEZE

Life of this patent

Estimating the term…

Abstract

The present invention relates to novel therapeutic approaches for treating cancer in mammals, particularly in human subjects, using an inhibitor of a PLA2-GIB cofactor.

Claims18

Dependent claims

1-31. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 16/976,088Filed 26 Feb 2019
Priority: EP 18305207.527 Feb 2018
Published: 24 Dec 2020
Term ends: Not estimatedThe source records don’t support an estimate.

Classification25 codes

C07K 16/2896
Against receptors, cell surface antigens or cell surface determinants: against molecules with a "CD"-designation, not provided for elsewhere
C12Y 301/01004
Carboxylic ester hydrolases: phospholipase A2
A61K 38/16
Medicinal preparations containing peptides: peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K 39/0216
Bacterial antigens: bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results